Risk Of Developing Liver Cancer After HCV Treatment

Wednesday, August 10, 2016

Hepatitis C – What Is Veterans Affairs Hiding For Profiteer Of Hep C Cure?

Hepatitis C – What Is Veterans Affairs Hiding For Profiteer Of Hep C Cure?


After CBS reported that Ray Schinazi made $400 million profit on a Hepatitis C cure, as a VA employee, the agency started playing a game of hide-the-pea.

The short version of Schinazi’s research were his discoveries of an HIV therapeutic and Hepatitis C cure. He developed those drugs while a full-time VA employee under his company named Pharmasset. Schinazi then sold Pharmasset to Gilead for $11 billion

Continue reading....


No comments:

Post a Comment